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INTRODUCTION
The use of plant-based materials in the treatment of human 
diseases and infections has become a common practice 
in many parts of the world, including Asia and Africa. 
The use of plant extracts in disease management has been 
linked to traditional knowledge of their efficacy. However, 
scientific investigations targeted at the characterization 
of phytochemical constituents of many medicinal plant 
species as well as their biological actions are increasing. 
In addition, increasing drug discovery efforts are targeted 
at identifying novel plant materials with medicinal effects 
or novel therapeutic applications of previously identified 
plants. As part of a program of investigation targeted at the 
characterization of biological effects of extracts of selected 
Nigerian plants commonly used in African trado-medicinal 
practices, we have reported hepatoprotective and antioxidant 
effects of Cymbropogon citratus, Azadirachta indica, Tamarindus 
indica, Eucalyptus camadulensis, Khaya senegalensis, and Camelia 
sinensis (Ojo and Ladeji, 2005; Ojo et al., 2005; Ojo et al., 
2006). Our preliminary studies also revealed that extracts 
of Psidium guajava, Anarcadium occidentale, and Moringa oleifera 
exhibited significant antidiabetic effects which are consistent 
with their traditional use in the management of diabetes 
(Omijeh et al., 2008, Tella et al., 2008, Olayaki et al., 2015).
Balanites aegyptiaca Del. (family Zygophyllaceae) is commonly 
known as desert date and is commonly found in Africa and 
South Asia (Hall and Waljer, 1991; Hall, 1992). Traditionally, 
extracts of the plant is used in the treatment of various 
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ABSTRACT
Traditional use of various extracts of Balanites aegyptiaca in the management of many diseases has been previously 
reported. Though oxidative stress is known to contribute to the development of many of the disease conditions 
on which extracts of B. aegytiaca have been found efficacious, effects of these extracts on free radical-induced 
lipid peroxidation is not well understood. This study investigated the protective effects of stem bark extracts of 
B. aegyptiaca on acetaminophen-induced lipid peroxidation in rats. Phytochemical analysis of the plant extract used 
was conducted. Following a 10 day pre-treatment with extracts of B. aegyptiaca, serum levels of thiobarbituric 
reactive substances (TBARS), vitamin C, cholesterol/phospholipids, catalase (CAT) activity as well as markers 
enzymes of hepatotoxicity were measured in rats administered with acetaminophen (2 mg/kg body weight). 
Results obtained indicated preponderance of alkaloids, flavonoids, glycosides, phenols, saponins, and tannins. 
Pre-treatment with extracts of B. aegyptiaca protected against acetaminophen-induced elevation of TBARS and 
marker enzymes of hepatotoxicity as well as inhibited the depletion of serum levels of vitamin C, CAT activity and 
phospholipids in a dose-dependent manner. Serum levels of cholesterol were not affected by acetaminophen 
intoxication or treatment with the plant extract. These results indicated that therapeutic actions previously 
linked with extracts of B. aegyptiaca might be a consequence of its antioxidative and hepatoprotective effects.
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ailments including jaundice, intestinal worm infection, 
wounds, malaria, syphilis, epilepsy, dysentery, constipation, 
diarrhoea, haemorrhoid, stomach aches, asthma, and fever 
(Watt and Breyer-Brandwijk, 1962; Beentje, 1994; Jagtap 
et al., 2009). Extracts of the plant have also been reported to 
exhibit spermicidal, antibacterial, antifungal, cardioprotective, 
anthelmintic, antitumor, antidiabetic and anti-inflammatory 
actions (Reviewed in Chothani and Vaghasiya, 2011). 
Phytochemical constituents previously isolated from various 
extracts of B. aegyptiaca include compounds belonging to 
saponin, furanocoumarin and flavonoids (Table 1). The 
role of oxidative stress in the development of many of the 
ailments against which extracts of B. aegyptiaca is active are 
well established (Madamanchi et al., 2005; Adly, 2010). 
However, it is not yet clear if B. aegyptiaca extracts exert its 
pharmacological effects by protecting against oxidative stress 
in vivo. Therefore in this study, we examined protective effects 
of aqueous extracts of B. aegyptiaca in acetaminophen-induced 
oxidative stress and lipid peroxidation in rats.
MATERIALS AND METHODS
Plant Materials
Fresh stem barks of B. aegyptiaca were collected in 
Sangere Village near Federal University of Technology, 
Yola. After botanical identification, a voucher specimen 
(No: BR2014-17) was deposited in the herbarium 
maintained at Bioscience Research Education and Advisory 
Centre. Stem barks were dried under room temperature 
and pulverized using mortar and pestle into fine powder. 
Powdered plant material (10 g) was soaked in 100 ml 
distilled water for 12 h and filtered using a Whatman’s 
No. 1 filter paper. The filtrate was concentrated using a 
vacuum concentrator and the residue was re-dissolved in 
distilled water to make a stock solution of 100 mg/ml 
which was stored at −20°C until used.
Phytochemical Screening
The aqueous extracts of B. aegytica stem bark was screened 
for the presence of saponins, tannins, triterpines, alkaloids, 
and flavonoids were carried out as previously described 
(Saeed et al., 2012).
Measurement of Total Phenolic and Total Flavonoid 
Contents
Total phenolic and phenolic contents of the aqueous stem 
bark extracts of B. aegyptiaca were estimated as previously 
described (Olayaki et al., 2015). Briefly, total phenolic 
content was estimated by Folin-Ciocalteu’s method 
following the protocol described by Kim et al. (2003) 
Table 1: List of active constituents isolated from extracts of Balanites aegytiaca
Phytochemical constituent Plant part References
3-rutinoside Fruit Salwa and Hadidi (1988)
3-rhamnogalactoside Fruit Salwa and Hadidi (1988)
Diosgenin Fruit Khare (2007)
26-(O-β-D-glucopyranosyl)-3-β-[4-O-(β-D-glucopyranosyl)-2-O-(α-L-rha
mnopyranosyl)-β-D-glucopyranosyloxy]-22,26-dihydroxyfurost-5-ene
Fruit kernel Staerk et al. (2007)
Balanitoside (furostanol glycoside) Fruit kernel Hosny et al. (1992)
6-methyldiosgenin Fruit mesocarp Hosny et al. (1992)
Balanitin-3 (spirostanol glycoside) Fruit mesocarp Kamel (1998)
Pregn-5-ene-3β,16β,20(R)-triol 3-O-(2,6-di-O-α-l-rhamnopyranosyl)-β-
d-glucopyranoside
Fruit mesocarp Gnoula et al. (2008), Pettit et al. (1991)
Pregn-5-ene-3β,16β,20(R)-triol 3-O-β-d-glucopyranoside Fruit mesocarp Kamel and Koskinen (1995)
25D-spirosta-3, 5-diene and 3β-chloro-25D-spirost-5-ene Leaves Saeed et al. (1995)
3β,12α,14β,16β)-12-hydroxycholest-5-ene-3,16-diyl 
bis(β-D-glucopyranoside
Root Hardman and Sofowora, (1970); Saharan et al., 
(2008)
3β,20S,22R,25R)-, and (3β,20S,22R,25S)-26-(β-D-glucopyranosyloxy)
-22-methoxyfurost-5-en-3-yl-β-D-xylopyranosyl-(1→3)-β-D-glucopyran
osyl-(1→4)[α-L rhamnopyranosyl-(1→2)]-β-D-glucopyranoside
Root Hardman and Sofowora, (1970); Saharan et al., 
(2008)
3β,20S,22R,25R)- spirost-5-en-3-yl β-D-xylopyranosyl-(1→3)-β-D-gluc
opyranosyl-(1→4) [α-L-rhamnopyranosyl-(1→2)]-β-D-glucopyranoside
Root Farid et al., (2002)
(3β,20S,22R,25S)-spirost-5-en-3-yl β-D-xylopyranosyl-(1→3)-β-D-gluc
opyranosyl-(1→4) [α-L-rhamnopyranosyl-(1→2)]-β-D-Glucopyranoside
Root Farid et al., (2002)
Furanocoumarin bergapten Bark Seida et al., (1981)
Dihydrofuranocumarin D- marmesin Bark Seida et al., (1981)
N-trans-feruloyltyramine Bark Sarker et al., (2000)
N-cis-feruloyltyramine Bark Sarker et al., (2000)
Vanillic acid Bark Sarker et al., (2000)
Syringic acid Bark Sarker et al., (2000)
3-hydroxy-1-(4-hydroxy-3-methoxyphenyl)-1-propanone Bark Sarker et al., (2000)
10-methyl-n-heptacosane Bark Ansari et al., (2006)
Diglucosyldirhamnoside Bark Ansari et al., (2006)
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and was expressed as gallic equivalent per gram of sample 
(GE/g). Similarly, estimation of total flavonoid content 
expressed as quercetin equivalents per gram sample 
(QE/g) was conducted as described by Park et al. (2008).
Experimental Animals
Male Wistar albino rats (average weight = 130 g) 
purchased from the animal house of University of Jos, 
Nigeria, were used for the study. Animals were maintained 
in an air-conditioned room (22 ± 2°C) with regulated 
light:dark cycle with food and water provided ad libitum. 
All animal experiments were carried out in accordance 
with the UK Animals (Scientific Procedures) Act 1986 
and EU Directive 2010/63EU for animal experiments.
In vivo Studies
Groups of rats (n = 6) were treated with once daily oral 
administration of either saline or graded doses of aqueous 
stem bark extracts of B. aegyptiaca (50-200 mg/kg body 
weight) for 10 days prior to a single oral overdose with 
acetaminophen (2 g/kg body weight). Another group of 
rats, treated with saline for 10 days and administered with 
saline instead of acetaminophen, was used as control. All 
animals were sacrificed within 12 h of acetaminophen 
administration under mild anesthesia. Serum was 
separated from terminal blood collected by heart puncture 
into heparinized bottles and stored at −20°C until used 
for biochemical analysis.
Determination of Lipid Peroxidation
Plasma concentrations of thiobarbituric reactive substances 
(TBARS) were measured as described by Buege and Aust 
(1978) to estimate the effect of the plant extract on lipid 
peroxidation experimental animals. Briefly, aliquots 
of plasma samples (0.8 ml) were mixed with 1.2 ml 
of TBA-reagent and heated in a boiling water bath for 
10 min. Tubes were allowed to cool down and were 
centrifuged at 300 rpm after the addition of 0.2 N NaOH 
(2 ml). Absorbance of the pink colored adduct formed 
was measured at 535 nm, and results were expressed as 
mmol/ml.
Assessment of Catalase (CAT) Activity
CAT activity in the erythrocyte lysates of treated and 
untreated animals was measured as described by Sinha 
(1972). Hydrogen peroxide (0.2 M) was used as a substrate 
and the decrease in the concentration of H
2
O
2
 at 22°C 
in phosphate buffer (0.05 M, pH 7.0) was measured by 
spectrophotometer at 240 nm. Enzyme activities were 
presented as units per gram hemoglobin (U/gHb).
Measurement of Biochemical Parameters
Serum levels of alanine transaminase (ALT), aspartic 
transaminase (AST) and alkaline phosphatise (ALP) 
were estimated to assess the effect of the plant extract 
on liver function in treated rats. Commercially, available 
kits (Randox Laboratories, UK) were used following 
the manufacturer’s recommended protocol. Similarly, 
serum cholesterol and phospholipids were estimated as 
previously described by Searcy et al. (1960) and Kobayashi 
et al., (2001) respectively. Serum ascorbic acid levels were 
measured by 2,4-dinitrophenlyhydrazine (DNPH) method 
through which vitamin C is oxidized to diketogluconic acid 
which reacts with DNPH to form diphenylhydrazone. The 
hydrazone dissolves in strong acid solution to form orange-
red colored complex. The absorbance was read at 520 nm.
Statistical Analysis
Results are expressed as mean ± standard error of the 
mean. Values were compared using one-way ANOVA 
followed by Student–Newman-Keuls post-hoc test. P < 0.05 
was considered statistically significant.
RESULTS
Phytochemical Constituents of Aqueous Stem Bark 
Extracts of B. aegyptiaca
Phytochemical screening of aqueous stem bark extracts 
of B. aegyptiaca indicated the preponderance of alkaloids, 
flavonoids, glycosides, phenols, saponins, and tannins. 
In addition, total flavonoids and phenolic contents of 
the extract were estimated as 67.14 ± 0.72 mg QE/g 
and 44.12 ± 0.39 mg GE/g, respectively. Values were 
interpolated using standard curves with R2 = 0.962 
or 0.945 for flavonoids or phenolic compounds, 
respectively.
Effects of Aqueous Stem Bark Extracts of 
B. aegyptiaca on Lipid Peroxidation, CAT Activity 
and Plasma Vitamin C Level
Basa l  p l a sma  TBARS leve l  was  obser ved  a s 
10.24 ± 2.20 nmol/l in saline treated rats. This was 
increased by 4.6-fold (P < 0.001, Figure 1a) in rats 
administered as single dose of paracetamol (2 g/kg body 
weight). However, elevated plasma TBARS concentrations 
caused by paracetamol intoxication was inhibited in a 
dose-dependent manner in rats pre-treated with aqueous 
stem bark extracts of B. aegyptiaca (23-60%, P < 0.01). 
CAT activity in rats administered acetaminophen was 
reduced by 75% (P < 0.001) compared with rats treated 
with saline (Figure 1b). Pre-treatment with aqueous 
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stem bark extracts of B. aegyptiaca resulted in increased 
CAT activities in rats intoxicated with acetaminophen. 
CAT activities increased by 1.4-fold in rats treated 
with 50 mg/kg body weight plant material compared 
with 2.8- and 3.1-fold (P < 0.001) observed in rats 
treated with high concentrations of the aqueous stem 
bark extracts. Moreover, treatment with acetaminophen 
decreased plasma vitamin C concentration by 54%. 
However, a concentration-dependent increase in plasma 
vitamin C concentration was observed in rats treated with 
aqueous stem bark extracts of B. aegyptiaca. Plasma vitamin 
C concentration increased by 1.3-fold (P < 0.05), 1.5-fold 
(P < 0.001), and 1.7-fold (P < 0.001) in rats treated with 
50, 100, and 200 mg/kg body weight of aqueous stem 
bark extracts of B. aegyptiaca, respectively, compared with 
saline-treated rats (Figure 1c).
Ef fects  o f  Aqueous Stem Bark  Ext racts 
of B. aegyptiaca on Plasma Cholesterol and 
Phospholipid Concentrations in Acetaminophen 
Treated Rats
Administration of acetaminophen did not affect plasma 
cholesterol levels (Figure 2a) but resulted in significantly 
reduced plasma phospholipid concentration (39%, 
P < 0.01, Figure 2b), leading to significantly higher 
cholesterol-phospholipid ratio (1.8-fold, P < 0.01) in 
Wistar albino rats. However, treatment with aqueous stem 
bark extracts of B. aegyptiaca inhibited the reduction in 
plasma phospholipid levels in acetaminophen treated rats 
(Figure 2c). Reduction in plasma phospholipid reduced (10-
31%, P < 0.01-0.05) in rats treated with aqueous stem bark 
extracts of B. aegyptiaca translated to 1.1-1.4-fold increase 
in cholesterol phospholipid ratio in that order (Figure 2).
Effects of Aqueous Stem Bark Extracts of 
B. aegyptiaca Extracts on Liver Function
As expected, elevated plasma levels of AST (5.9-fold, 
P < 0.001), ALT (6.6-fold, P < 0.001) and ALP (4.2-fold, 
P < 0.001) were observed in acetaminophen-intoxicated 
rats (Figure 3). Treatment with aqueous stem bark extracts 
of B. aegyptiaca significantly inhibited elevation of plasma 
levels of these enzymes in a dose-dependent manner. 
In rats treated with 50 mg/kg body weight, plasma 
AST, ALT, and ALP were reduced by 35.5% (P < 0.01), 
41.4% (P < 0.001), and 25.8% (P < 0.05), respectively, 
compared to saline-treated rats. The highest concentration 
of the aqueous stem bark extracts of B. aegyptiaca tested 
produced 63% (P < 0.001), 72% (P < 0.001), and 54% 
(P < 0.01) reduction in plasma AST, ALT, and ALP in 
acetaminophen-treated rats.
DISCUSSION
Oxidative stress reflects an imbalance between the 
productions of reactive oxygen species (ROS), arising 
from effects of ionizing radiation, free radicals and other 
systemic sources, and the ability of a biological system to 
detoxify the reactive intermediates or repair damage caused 
Figure 1: Effects of Balanites aegyptiaca extracts on serum levels of (a) thiobarbituric reactive substances, (b) catalase activity and (c) vitamin C in 
acetaminophen-treated rats. Values are mean ± standard error of the mean with n = 6. *P < 0.05, **P < 0.01 and ***P < 0.001 compared with 
saline treated rats. ∆P < 0.05, ∆∆P < 0.01 and ∆∆∆P < 0.001, compared with acetaminophen-treated control rats
c
ba
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by ROS (Imlay, 2003). This process has been implicated in 
the etiology of many human disease conditions, including 
inflammation, reperfusion injury, diabetes, cancer, 
myocardial infarction, and Alzheimer’s disease (Singh 
et al., 1995; Nunomura et al., 2005; Halliwell, 2007; 
Ramond et al., 2011; Pohanka, 2013). Lipid peroxidation 
is a biologically-important consequence of increased 
production of ROS and has been recognized as a biomarker 
for oxidative stress (Niki, 2008). Acetaminophen is widely 
used as analgesic and antipyretic and is considered safe at 
therapeutic doses. However, at doses above 2 g/kg body 
weight, acetaminophen consumption has been linked with 
hepatic centrilobular necrosis and lipid peroxidation in 
experimental animals (Rowden et al., 2006). It has been 
suggested that acetaminophen’s metabolite, N-acetyl-P 
benzoquinone imine, binds to sulphydryl groups of protein 
in the liver to induce cell necrosis and lipid peroxidation 
(Boyd and Bereczky, 1966; Hinson et al., 2010). This has 
also been linked with increased circulating concentrations 
of alanine and aspartate transaminases (ALT and AST) 
Figure 2: Effects of Balanites aegyptiaca extracts on serum levels of (a) cholesterol, (b) phospholipids and (c) cholesterol-phospholipids ratio in 
acetaminophen-treated rats. Values are mean ± standard error of mean with n = 6. *P < 0.05 and **P < 0.01 compared with saline treated rats. 
∆P < 0.05 and ∆∆P < 0.01 compared with acetaminophen-treated control rats
c
ba
Figure 3: Effects of Balanites aegyptiaca extracts on serum levels of (a) aspartic transaminase, (b) alanine transaminase and (c) alkaline 
phosphatise in acetaminophen-treated rats. Values are mean ± standard error of the mean with n = 6. *P < 0.05, **P < 0.01 and ***P < 0.001 
compared with saline treated rats. ∆P < 0.05, ∆∆P < 0.01 and ∆∆∆P < 0.001 compared with acetaminophen-treated control rats
c
ba
Ojo, et al.: Hepatoprotective and antioxidant effi cacy of Balanites aegyptiaca
94 Journal of Medicinal Herbs and Ethnomedicine ● Vol 1 ● 2015
(Drotman and Lawhorn, 1978, Aleksunes et al., 2006), 
ALP and γ-glutamyl transpeptidase (Muriel et al., 1992).
Consistent with these observations, rats intoxicated 
with acetaminophen in the present study exhibited 
increased lipid peroxidation, indicated by elevated serum 
TBARS and significantly reduced serum CAT activity 
and vitamin C contents, compared with saline treated 
controls. However, reduced serum TBARS accompanied 
by significantly elevated serum CAT activity and 
vitamin C concentration were observed in rats treated 
with aqueous stem bark extracts of B. aegyptiaca, indicating 
the ability of the plant extract to protect rats from the 
deleterious effects of acetaminophen intoxication. TBARS 
are degradation products of lipids which accumulates 
in the serum in the event of lipid peroxidation (Janero, 
1990) and CAT catalyzes the decomposition of hydrogen 
peroxide to oxygen and water, thereby protecting the 
cell from ROS-induced oxidative damage (Chelikani 
et al., 2004). Therefore, the reduced serum TBARS level 
together with the increased CAT activity observed in 
aqueous stem bark extracts of B. aegyptiaca treated rats 
is indicative of the ability of the plant extract to protect 
against lipid peroxidation/oxidative damage arising from 
acetaminophen intoxication. Moreover, the increased 
serum vitamin C concentration in rats treated with the 
plant extract is also an indication of a good antioxidant 
status (Padayatty et al., 2003). Al-Ghannam et al. (2013) 
reported that balanitoside; a diosgenyl saponin isolated 
from the B. aegyptiaca fruit, exhibited antitumor effects 
and decreased the formation of malondialdehyde in Ehrlich 
ascites carcinoma bearing Swiss albino mice. Consistent 
with our observation, increased CAT activities and other 
parameters indicating reduced lipid peroxidation were also 
observed in balanitoside-treated mice. These observations 
suggest that balanitoside may be the active compound 
responsible for the effects observed in this study. However, 
further structural characterization studies are needed to 
confirm this speculation.
Cholesterol-phospholipid ratio was measured to 
investigate the effect of acetaminophen intoxication 
on cell membrane integrity in rats (Fajardo et al., 
2011). Consistent with our previous observations (Ojo 
et al., 2006), elevated cholesterol-phospholipid ratio 
was observed in saline treated rats intoxicated with 
acetaminophen. This effect was however countered 
in rats treated with the aqueous stem bark extracts of 
B. aegyptiaca. This observation indicates the ability of the 
plant extract to protect against the alteration of lipid 
membranes in acetaminophen intoxication. Impaired 
liver function following acetaminophen intoxication 
has been reported widely (Olayaki et al., 2015). 
However, elevated serum levels of alanine and aspartate 
transaminases caused by acetaminophen intoxication was 
inhibited in rats treated with aqueous stem bark extracts 
of B. aegyptiaca, indicating the hepatoprotective actions 
of the plant extract. Though the molecular mechanism 
underlying the hepatoprotective actions of the plant 
extract is not yet known, inhibition of hepatic damage has 
been reported for many plant species commonly used in 
African traditional medicinal practices.
CONCLUSION
Observations reported in this study together with 
previously reported pharmacological actions strongly 
necessitate the investigations of therapeutic application 
of compounds derived from aqueous stem bark extracts 
of B. aegyptiaca as agents with multiple actions. For 
instance, the reported antimicrobial (Jahan et al., 2013) 
and antitumor (Al-Ghannam et al., 2013) activities 
reported for balanitoside represents a combination of 
effects that could be beneficial in treating infections in 
cancer patients.
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